Merck Tbk. vs Rohartindo Nusantara Luas Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Rohartindo Nusantara Luas Tbk. trades at Rp69 (market cap 141.45B, 20.96M 24h volume). The key difference: Merck Tbk. is far larger — about 12× Rohartindo Nusantara Luas Tbk.'s market cap, and Rohartindo Nusantara Luas Tbk. is more actively traded (20.96M versus 37.6K). Which is the better fit depends on your goals.
| MERK | TOOL | |
|---|---|---|
Market Cap | 1.7T | 141.45B |
Volume | 37.6K | 20.96M |
Lot | 376 | 209.65K |
Turnover | 144.47M | 1.44B |
Average Price | 3,842.23 | 68.75 |
Value | 144.47M | 1.44B |
Indicative Equilibrium Price | 3,840 | 69 |
Indicative Equilibrium Volume | 7 | 9.21K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Rohartindo Nusantara Luas Tbk ("The Company") was established based on Notarial Deed of Sudiono Abady, S.H., No. 2 dated October 4, 2014. The Company started its commercial operations in June 2015.
Read more on TOOL →